Cargando…

Megalin/lipoprotein receptor-related protein 2 autoimmunity and kidney disease

In this issue of Clinical Kidney Journal, Gamayo et al. describe two cases of anti-low-density lipoprotein receptor-related protein 2 (LRP2) nephropathy. This is a recently described entity that has features of both tubulointerstitial disease and segmental membranous nephropathy. The originality of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perez-Gomez, Maria V, Sanchez-Niño, Maria D, Ortiz, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Editorial Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367110/ https://www.ncbi.nlm.nih.gov/pubmed/32701075 http://dx.doi.org/10.1093/ckj/sfz171

Ejemplares similares

Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney disease
por: Fernandez-Prado, Raul, et al.
Publicado: (2020)

Probiotics for kidney disease
por: Favero, Chiara, et al.
Publicado: (2022)

Klotho, the elusive kidney-derived anti-ageing factor
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2019)

Who killed Bruce Lee? The hyponatraemia hypothesis
por: Villalvazo, Priscila, et al.
Publicado: (2022)

The dirty little secret of urate-lowering therapy: useless to stop chronic kidney disease progression and may increase mortality
por: Gonzalez-Martin, Guillermo, et al.
Publicado: (2020)

Autosomal dominant polycystic kidney disease: possibly the least silent cause of chronic kidney disease
por: Torra, Roser, et al.
Publicado: (2021)

EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors
por: Fernández-Fernandez, Beatriz, et al.
Publicado: (2023)

Solving the riddle of Aguascalientes nephropathy: nephron number, environmental toxins and family clustering
por: Villalvazo, Priscila, et al.
Publicado: (2022)

European East–West divide in kidney disease: the need to understand the drivers of chronic kidney disease outcomes
por: Carriazo, Sol, et al.
Publicado: (2020)

NephroCheck at 10: addressing unmet needs in AKI diagnosis and risk stratification
por: Martin-Cleary, Catalina, et al.
Publicado: (2023)

RICORS2040: the need for collaborative research in chronic kidney disease
por: Ortiz, Alberto
Publicado: (2021)

More on the invisibility of chronic kidney disease… and counting
por: Carriazo, Sol, et al.
Publicado: (2021)

Lipoprotein(a): An Enigmatic Sheep in the Lipoprotein Herd
por: Shapiro, Michael D., et al.
Publicado: (2020)

Stopping kidney protection in the elderly following acute kidney injury: think mortality
por: Carriazo, Sol, et al.
Publicado: (2022)

Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrology
por: Carriazo, Sol, et al.
Publicado: (2020)

Optimizing the timing of nephrology referral for patients with diabetic kidney disease
por: Martínez-Castelao, Alberto, et al.
Publicado: (2020)

Kidney disease and electrolytes in COVID-19: more than meets the eye
por: Carriazo, Sol, et al.
Publicado: (2020)

The unaccomplished mission of reducing mortality in patients on kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2020)

Coordinating efforts to optimize next-generation kidney replacement therapies: the European Kidney Health Alliance Work Group ‘Breakthrough Innovation’
por: Wieringa, Fokko, et al.
Publicado: (2023)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2020)

Farewell from the CKJ Editor-in-Chief: key kidney topics from 2014 to 2021
por: Ortiz, Alberto, et al.
Publicado: (2022)

Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT
por: Sarafidis, Pantelis, et al.
Publicado: (2020)

Nicotinamide and acute kidney injury
por: Fontecha-Barriuso, Miguel, et al.
Publicado: (2021)

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association
por: Ortiz, Alberto, et al.
Publicado: (2022)

The last pre-pandemic European Renal Association Registry report: age at start of kidney replacement therapy in Europe
por: Carriazo, Sol, et al.
Publicado: (2021)

Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solved
por: Villalvazo, Priscila, et al.
Publicado: (2021)

Gain-of-function TLR7 and loss-of-function A20 gene variants identify a novel pathway for Mendelian lupus and lupus nephritis
por: Villalvazo, Priscila, et al.
Publicado: (2022)

The fast-recycling receptor Megalin defines the apical recycling pathway of epithelial cells
por: Perez Bay, Andres E., et al.
Publicado: (2016)

Lipoprotein (a): A Frustrating Final Frontier in Lipid Management?
por: Libby, Peter
Publicado: (2016)

The Endocytic Receptor Megalin and its Associated Proteins in Proximal Tubule Epithelial Cells
por: De, Shankhajit, et al.
Publicado: (2014)

Neuronal megalin mediates synaptic plasticity—a novel mechanism underlying intellectual disabilities in megalin gene pathologies
por: Gomes, João R, et al.
Publicado: (2020)

Lipoprotein(a): A Taxi for Autotaxin Takes a Toll in Calcific Aortic Valve Disease
por: Towler, Dwight A.
Publicado: (2017)

Functional respiratory impairment and related factors in patients with interstitial pneumonia with autoimmune features (IPAF): Multicenter study from NEREA registry
por: Nieto, Maria Asuncion, et al.
Publicado: (2023)

Megalin and Vitamin D Metabolism—Implications in Non-Renal Tissues and Kidney Disease
por: Khan, Sono S., et al.
Publicado: (2022)

Diagnosis 101: diabetic kidney disease
por: Lerma, Edgar V
Publicado: (2022)

Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk?
por: Vavlukis, Marija
Publicado: (2017)

Megalin: a Novel Determinant of Renin-Angiotensin System Activity in the Kidney?
por: Sun, Yuan, et al.
Publicado: (2020)

Functional megalin is expressed in renal cysts in a mouse model of adult polycystic kidney disease
por: Nielsen, Marlene L, et al.
Publicado: (2021)

Soluble Megalin is Reduced in Cerebrospinal Fluid Samples of Alzheimer’s Disease Patients
por: Spuch, Carlos, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fr5hnvutlobs253j5rof1orar7